Login / Signup

Hexokinase inhibition using D-Mannoheptulose enhances oncolytic newcastle disease virus-mediated killing of breast cancer cells.

Ahmed Ghdhban Al-ZiaydiAhmed Majeed Al-ShammariMohammed I HamzahHaider Sabah KadhimMajid Sakhi Jabir
Published in: Cancer cell international (2020)
The combination treatment showed safe significant tumor cell proliferation inhibition compared to monotherapies suggesting a novel strategy for anti-breast cancer therapy through glycolysis inhibition by hexokinase downregulation.
Keyphrases
  • disease virus
  • cell proliferation
  • cancer therapy
  • breast cancer cells
  • drug delivery
  • signaling pathway
  • combination therapy
  • replacement therapy